Ventilatory Power: a Novel Index That Enhances Prognostic Assessment of Patients with Heart Failure
Overview
Authors
Affiliations
Background: Minute ventilation/CO(2) production (VE/Vco(2)) slope is an index determined by cardiopulmonary exercise testing, which incorporates pertinent cardiac, pulmonary, and skeletal muscle physiology into a substantive composite assessment. The VE/Vco(2) slope has many applications, including utility as a well-validated prognostic gauge for patients with heart failure (HF). In this study, we combine VE/Vco(2) slope with systolic blood pressure, creating a novel index that we labeled ventilatory power. Ventilatory power links the combined physiology inherent in the VE/Vco(2) slope to peripheral pressure, adding an additional dimension pertinent to HF assessment. Whereas the related concept of circulatory power links peak oxygen consumption with peak systolic blood pressure as a prognostic index, we hypothesized that ventilatory power would provide greater prognostic discrimination than VE/Vco2 slope, peak oxygen consumption, and circulatory power for patients with systolic HF.
Methods And Results: Patients with systolic HF (left ventricular ejection fraction ≤35%) underwent symptom-limited cardiopulmonary exercise testing as part of routine management and were followed for up to 4 years for major cardiac events (mortality, left ventricular assist device implantation, and heart transplantation). Eight hundred seventy-five patients with HF (left ventricular ejection fraction, 26±9%; mean age, 55±14) were studied. Cardiopulmonary exercise testing indices peak oxygen consumption, VE/Vco(2) slope, circulatory power, and ventilatory power were all predictive of cardiac events (P<0.001). Multivariate analysis demonstrated that ventilatory power was the strongest indicator of prognosis.
Conclusions: Although circulatory power and traditional cardiopulmonary exercise testing parameters can be used to predict prognosis among patients with HF, ventilatory power provides relatively greater prognostic discrimination and may constitute a relatively more useful composite tool.
Back G, Oliveira M, Areas G, Camargo P, da Luz Goulart C, de Oliveira C Physiol Rep. 2025; 13(5):e70216.
PMID: 40025655 PMC: 11872806. DOI: 10.14814/phy2.70216.
Tuan S, Huang I, Huang W, Chen G, Sun S, Lin K Life (Basel). 2024; 14(11).
PMID: 39598227 PMC: 11595789. DOI: 10.3390/life14111429.
Brazilian Guideline for Exercise Test in the Adult Population - 2024.
Carvalho T, Freitas O, Chalela W, Hossri C, Milani M, Buglia S Arq Bras Cardiol. 2024; 121(3):e20240110.
PMID: 38896581 PMC: 11656589. DOI: 10.36660/abc.20240110.
Wernhart S, Michel L, Carpinteiro A, Luedike P, Rassaf T Curr Heart Fail Rep. 2024; 21(3):224-237.
PMID: 38635117 PMC: 11090960. DOI: 10.1007/s11897-024-00661-1.
Exercise, cancer, and the cardiovascular system: clinical effects and mechanistic insights.
Wernhart S, Rassaf T Basic Res Cardiol. 2024; 120(1):35-55.
PMID: 38353711 PMC: 11790717. DOI: 10.1007/s00395-024-01034-4.